Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Randomized Controlled Trial of Repeated Dose Ketamine in Post Traumatic Stress Disorder (PTSD)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02398136

Organisation Name: Icahn School of Medicine at Mount Sinai

Overal Status: Withdrawn

Start Date: December 2014

Last Update: March 25, 2015

Lead Sponsor: Adriana Feder

Brief Summary: The purpose of this study is to see whether ketamine, when given repeatedly via the nose (intranasally), can produce a quick and persistent improvement in PTSD symptoms. At higher doses, ketamine has been used for many years as an anesthetic for medical procedures, and at lower doses may be an effective treatment in patients with major depression and PTSD.

Conditions:
  • PTSD


Total execution time in seconds: 0.16090703010559